These data come from Cosmos, a collaboration of Epic health systems representing more than 233 million patient records from 1,325 hospitals and more than 28,900 clinics from all 50 states and Lebanon
According to the FDA and Eli Lilly, you should not take Foundayo if you (1, 3): Have a personal or family history of medullary thyroid carcinoma Have Multiple Endocrine Neoplasia syndrome type 2 Are currently taking another GLP-1 receptor agonist medication Foundayo has not been studied in children (3)
If your insurance doesnt cover the required initial blood work, you are responsible for paying the lab facility
Many people stop taking them because of those side effects and, perhaps even more so, cost and insurance barriers
Retrieved December 10, 2024, from [10] Long-Term Efficacy and Safety of Once-Weekly Semaglutide for Weight Loss in Patients Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Moiz, Areesha et al
Research on injection safety consistently shows that proper rotation prevents this entirely
